Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.
A new Phase 2 clinical trial will continue to assess the safety and effectiveness of the non-opioid small molecule candidate therapy NYX-2925, developed by Aptinyx, in fibromyalgia patients. NYX-2925 is an ... Read more
An approved medication, Cymbalta (duloxetine) is effective at easing pain in fibromyalgia (FM) patients, a large meta-analysis shows. A daily 60 mg dose is enough to trigger therapeutic benefits with ... Read more
Tonix Pharmaceuticals has been granted a U.S. patent for its investigational therapy TNX-102 SL (cyclobenzaprine HCl sublingual tablets), designed to treat fibromyalgia, among other indications. Issued by the U.S. ... Read more
Aptinyx’s NYX-2925 treatment candidate continues to significantly reduce the levels of a brain biomarker associated with pain severity, called glutamine (Glx), in people with fibromyalgia, top line results of ... Read more
Women with fibromyalgia (FM) show reduced strength in the pelvic muscles, which correlates with urinary dysfunction and worse quality of life, a study reports. The study, “Lower urinary tract ... Read more
The keys to building better doctor-patient relationships are sharing information and responsibilities, and finding providers with the right ‘fit,’ according to researchers, who said people with fibromyalgia repeatedly experience ... Read more
Childhood sexual abuse produces post-traumatic physical and psychological distress that can alter brain connectivity and lead to fibromyalgia, researchers say. Their study found that supplying the brain with oxygen ... Read more